Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel SERM devoid of uterotrophic effects presented at Breast Cancer Symposium

Dec. 7, 2000

Progen completes patient recruitment for phase Ib trial of PI-88 in cancer

Dec. 6, 2000

Hematology news: LY-294002 activates apoptotic pathway in myeloid leukemia cells

Dec. 5, 2000

Chemically modified homoharringtonine analogue retains activity against resistant leukemia cells

Dec. 5, 2000

Anticancer tyrosine kinase inhibitors covered in patent issued to American Cyanamid

Dec. 5, 2000

Genzyme Transgenics to produce huN901 for ImmunoGen

Dec. 5, 2000

BioChem Pharma's Troxatyl to enter new clinical trial for CML-BP treatment

Dec. 5, 2000

INGN-241 is third Introgen drug candidate to enter clinical trials

Dec. 5, 2000

Korean researchers discover new series of protein farnesyltransferase inhibitors

Dec. 4, 2000

Japanese patent covers new steroidal antiproliferative compounds identified at Kaneka

Dec. 4, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...